anti-gremlin-1 monoclonal antibody UCB6114
Term · Oncology and biomedicine · MLC-T-ONC-010723
A monoclonal antibody directed against gremlin-1 (GREM1; Drm), with potential antineoplastic activity. Upon administration, anti-gremlin-1 antibody UCB6114 specifically targets and binds to gremlin-1, thereby neutralizing Gremlin-1. This may block the gremlin-1-mediated inhibition of bone morphogenetic protein (BMP) signaling pathways, and may lead to the inhibition of tumor cell growth and proliferation. Gremlin-1, a BMP antagonist that is overexpressed in a variety of cancer cell types, is involved in cancer cell growth and proliferation as well as tissue fibrosis.
| Identifier | MLC-T-ONC-010723 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-GREM1 antibody monoclonal UCB6114 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010723",
"term": "anti-gremlin-1 monoclonal antibody UCB6114",
"field": "Oncology and biomedicine",
"definition": "A monoclonal antibody directed against gremlin-1 (GREM1; Drm), with potential antineoplastic activity. Upon administration, anti-gremlin-1 antibody UCB6114 specifically targets and binds to gremlin-1, thereby neutralizing Gremlin-1. This may block the gremlin-1-mediated inhibition of bone morphogenetic protein (BMP) signaling pathways, and may lead to the inhibition of tumor cell growth and proliferation. Gremlin-1, a BMP antagonist that is overexpressed in a variety of cancer cell types, is involved in cancer cell growth and proliferation as well as tissue fibrosis.",
"synonyms": [
"anti-GREM1 antibody monoclonal UCB6114"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-gremlin-1-monoclonal-antibody-ucb6114/"
}
Record 1,831 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.